Novavax | NVAX - Lieferungen Und Leistungen





Lieferungen Und Leistungen Veränderung Datum
Adma Biologics USD 158.43M 20.76M 2025-12
Agenus USD 22.44M 1.14M 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
Cassava Sciences USD 120K 697K 2025-12
Geron USD 37.66M 1.71M 2025-09
GlaxoSmithKline GBP 7.76B 545M 2025-12
MannKind USD 38.37M 20.98M 2025-12
Merck USD 12.12B 596M 2025-09
Moderna USD 184M 862M 2025-12
Novartis USD 12.29B 3.3B 2025-12
Novavax USD 106.45M 72.27M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Sanofi EUR 397M 100M 2025-12
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
TG Therapeutics USD 265.38M 33.86M 2025-09